Biologic drugs for severe asthma
CADTH
Record ID 32018005467
English
Details
Project Status:
Ongoing
URL for project:
https://www.cadth.ca/biologic-drugs-severe-asthma
Anticipated Publish Date:
2024
English language abstract:
An English language summary is available
Publication Type:
Mini HTA
Country:
Canada
MeSH Terms
- Asthma
- Biological Products
- Anti-Asthmatic Agents
- Antibodies, Monoclonal, Humanized
- Omalizumab
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
<p>Canadian Agency for Drugs and Technologies in Health (CADTH)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.